Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2018 Mar 6.
Published in final edited form as: Am J Infect Control. 2017 Dec 1;45(12):1405–1406. doi: 10.1016/j.ajic.2017.10.002

Journal Club: Risk Factors for MRSA Colonization in the Neonatal ICU: A Systematic Review and Meta-analysis

Heather M Gilmartin 1, Amanda Hessels 2
PMCID: PMC5839134  NIHMSID: NIHMS945109  PMID: 29195585

Abstract

The topic of this Journal Club is a commentary on the article “Risk factors for MRSA colonization in the neonatal ICU: A systematic review and meta-analysis” by Matthew Washam, M.D., M.P.H.; Jon Woltmann, M.D.; Beth Haberman, M.D.; David Haslam, M.D.; and Mary Allen Staat, M.D., M.P.H., from the Cincinnati Children’s Hospital. Eleven studies that reported risk factors for MRSA colonization using non-colonized controls in subspecialty level III or IV neonatal intensive care units (NICUs) were included in the systematic review and 10 articles underwent meta-analysis. The findings of the study indicate that the most commonly reported risk factors for methicillin-resistant staphylococcus aureus (MRSA) colonization in this sample was gestational age <32 weeks and very-low birth weight (<1500 grams). Infant gender, race, inborn status, and delivery type were not significantly associated with colonization.

Keywords: MRSA, Colonization, NICU, Systematic Review, Meta-analysis

BACKGROUND

Outbreaks of MRSA infections in NICUs have been described since the 1980’s.1 Though MRSA infections are becoming less common in adult patients, they continue to be a concern in NICUs.2 Efforts to eradicate and control MRSA colonization in this highly vulnerable patient population have had variable degrees of success.3 Strategies such as basic infection control measures, (e.g., education, observation, and feedback on standard precaution practices, routine environmental cleaning, isolation of colonized or infected infants)1,3 to active surveillance, 1,3 to aggressive infection control measures (e.g. decolonization of infants and healthcare workers1 or molecular typing1,3) have been reported. Because colonization is a major independent risk factor for infection,4 and colonized neonates play a major role as endogenous reservoirs of MRSA in the NICU setting, 5 identifying infants at high risk for MRSA colonization is an important infection prevention and control strategy.

Multiple individual studies have reported risk factors for MRSA colonization in NICUs. Though informative, single studies can be unrepresentative of the total evidence and can be misleading.6 Due to this, it is generally advised that clinical or policy decisions be based on the totality of the best evidence and not the results of individual studies.6 Systematic reviews synthesize the findings of individual studies that address a focused clinical question using a structured and reproducible approach.7 They are often accompanied by a meta-analysis, which is an aggregation of results from different studies providing a single estimate of effect.7 Systematic reviews help clinicians keep up-to-date with their field and are often used as the starting point for developing clinical practice guidelines.8

The benefits of systematic reviews with meta-analysis are the greater range and number of patients and events included, more than any single study could report. This can potentially lead to greater precision of estimates and enhanced confidence in applying the results to clinical care.7 Meta-analysis also provides an opportunity to explore reasons for inconsistency between individual studies.7 Limitations of systematic reviews and meta-analyses are they are only as reliable as the studies they summarize and as credible as the design and conduct of the review.7 To assist clinicians in assessing the reliability and credibility of systematic reviews, reporting guidelines, such as the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) are available to gauge the completeness and transparency of the review methods.8 A previous review has been performed summarizing the significance, burden, and time trends of MRSA colonization in NICUs. 2 The study by Washam et al., highlighted in this Journal Club commentary, extends this topic by focusing specifically on risk factors for MRSA colonization in the NICU.

ARTICLE OVERVIEW

The objective of this systematic literature review with meta-analysis was to assess the literature for MRSA colonization risk factors in the NICU and to quantitatively analyze the most commonly reported risk factors. The authors employed a detailed and precise approach and followed PRISMA-P guidelines, thereby enhancing the reliability and credibility of the results. The study comprehensively reviewed existing literature from inception through September 2015. Following identification of articles that met the inclusion criteria, the data were methodically extracted by two independent authors. The quality of included studies were objectively assessed using a modified Newcastle-Ottawa Scale and consensus on rating was measured using Cohen’s kappa statistic. The screening process is appropriately presented in Figure 1.

Ultimately, 11 studies were included; eight of which were deemed high quality and three rated as fair quality. Retained studies included a range of designs, including retrospective cohort, prospective, cohort, case-control and cross-sectional. The studies were pooled when appropriate, with some statistical models run with data from six studies whereas others included data from five. This was important to allow for meta-analysis of similar data from similar studies.

Following the examination and pooling of data, multiple statistical models were calculated to examine specific risk factors, including: a) gestational age, b) birth weight, c) gender, race, d) inborn/outborn, and e) delivery type. Of these potential risk factors for MRSA colonization, the findings supported two: gestational age and birth weight. Specially, the odds of MRSA colonization are more than two and half times greater if gestational age is <32 weeks compared to not, or birthweight is <1500 grams compared to not. Gender, race, inborn/outborn, and delivery type were not associated with MRSA colonization in NICU infants. Additionally, the authors reported an array of potential and important risk factors from the systematic review that were not included in the meta-analysis (Table 2). This is valuable information to readers of the review.

DISCUSSION AND IMPLICATIONS FOR INFECTION PREVENTIONISTS

Guided by a Critical Appraisal Skills Programme Checklist we found the results of this review to be valid and have potential to inform clinical practice.9 Specially, this review addressed a clearly focused question, authors comprehensively searched a large amount of literature, important and relevant studies were included, the authors thoroughly assessed the quality of the included studies, it was reasonable to combine results of the studies as performed, the results are precise as shown by confidence intervals and interpretations, and all important predictors and outcomes were considered.9 The article’s structure and clear and efficient language and graphics allows the reader to easily understand a comprehensive and complex literature review. One clarification that would strengthen this article is providing precise time-range for study articles (e.g. not “since inception”) and an explanation as to why the review was not updated past 2015. For the reader, it is always important to check the literature to make sure it is the most up-to-date review. This study is an excellent example of how systematic literature reviews and meta-analysis should be performed to advance science.

The key findings from this systematic review and meta-analysis affirm our knowledge of the high risk for adverse outcomes of low birth weight and early gestational age infants, expanding the risk to include MRSA colonization. Unfortunately, the review did not identify any modifiable risk factor with MRSA colonization, suggesting that there is no “magic bullet” that will prevent ongoing transmission within NICUs. Clinical implications for administrators, front line clinicians, environmental staff and infection preventionists include: 1) efforts to ensure consistent and reliable delivery of existing best practices must be robust, and 2) comprehensive strategies to decrease the potential burden in the NICU in general from MRSA contamination of the environment and colonization of infants should be considered.

An important research implication for infection preventionists, clinicians and administrators is that this study affirms that high-quality research from individual settings have the potential to generate knowledge and implications for practice for the broader community. For the busy IP this means that studies that examine local data, such as case-control, cohort or cross sectional studies, can impact global practice, as demonstrated in this review. Due to this, IPs should consider seeking opportunities to participate in local research. Additionally, if working with a highly specialized population such as in a NICU, consider seeking out opportunities to participate in infection prevention multi-site projects to fill the void as suggested in the article. Finally, the importance of disseminating research work and findings from practice is of paramount importance as exemplified by the synthesis of additional risk factors by Washman et al. 2017.

Acknowledgments

Journal Club is an ongoing activity of the Association for Professionals in Infection Control and Epidemiology Research Committee. As part of this activity, research committee members comment on select articles to demonstrate research implications for infection preventionists.

Footnotes

Disclaimer: The contents of this manuscript do not represent the views of the Department of Veterans Affairs or the United States Government.

Conflicts of Interests: None to report

Contributor Information

Heather M. Gilmartin, Denver/Seattle Center of Innovation for Veteran-Centered and Value Driven Care, VA Eastern Colorado Healthcare System, 1055 Clermont Street, Denver, CO 80220, U.S.A. 970-857-5097.

Amanda Hessels, Associate Research Scientist, Columbia University, School of Nursing.

References

  • 1.Khoury J, Jones M, Grim A, Dunne WM, Fraser V. Eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit by active surveillance and aggressive infection control measures. Infection Control & Hospital Epidemiology. 2005;26(7):616–621. doi: 10.1086/502590. [DOI] [PubMed] [Google Scholar]
  • 2.Zervou FN, Zacharioudakis IM, Ziakas PD, Mylonakis E. MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics. 2014;133(4):e1015–e1023. doi: 10.1542/peds.2013-3413. [DOI] [PubMed] [Google Scholar]
  • 3.Giuffrè M, Amodio E, Bonura C, et al. Methicillin-resistant Staphylococcus aureus nasal colonization in a level III neonatal intensive care unit: Incidence and risk factors. American journal of infection control. 2015;43(5):476–481. doi: 10.1016/j.ajic.2014.12.027. [DOI] [PubMed] [Google Scholar]
  • 4.Huang Y-C, Chou Y-H, Su L-H, Lien R-I, Lin T-Y. Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics. 2006;118(2):469–474. doi: 10.1542/peds.2006-0254. [DOI] [PubMed] [Google Scholar]
  • 5.Gerber SI, Jones RC, Scott MV, et al. Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infection Control & Hospital Epidemiology. 2006;27(2):139–145. doi: 10.1086/501216. [DOI] [PubMed] [Google Scholar]
  • 6.Murad MH, Montori VM. Synthesizing evidence: shifting the focus from individual studies to the body of evidence. JamaJAMA. 2013;309(21):2217–2218. doi: 10.1001/jama.2013.5616. [DOI] [PubMed] [Google Scholar]
  • 7.Murad MH, Montori VM, Ioannidis JP, et al. How to read a systematic review and meta-analysis and apply the results to patient care: users’ guides to the medical literature. JAMA. 2014;312(2):171–179. doi: 10.1001/jama.2014.5559. [DOI] [PubMed] [Google Scholar]
  • 8.Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic reviews. 2015;4(1):1. doi: 10.1186/2046-4053-4-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Critical Appraisal Skills Programme. [Accessed: 09/25/2017];CASP Systematic Review Checklist [online] 2017 Available at: http://www.casp-uk.net/casp-tools-checklists.

RESOURCES